Rezolute Common Stock (NV) share price logo

Rezolute Common Stock (NV)

NASDAQ: RZLT

Small Cap

$5.03

+0.14

(+2.76%)

Live

as on

Rezolute Common Stock (NV) Stock Performance

as on June 25, 2026 at 6:27 am IST

  • Day's Low

    Day's High

    $4.90
    $5.25
    downward going graph

    2.58%

    Downside

    4.37%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.07
    $11.46
    downward going graph

    78.73%

    Downside

    127.76%

    Upside

    downward going graph

Rezolute Common Stock (NV) share price movements today

Previous Close
$4.89
Open
$4.90
Volume
2.9M
Day's Low - High
$4.90 - $5.25
52 Week Low - High
$1.07 - $11.46

Rezolute Common Stock (NV) Historical Returns

1 Month Return
+ 50.46 %
3 Month Return
+ 81.78 %
1 Year Return
+ 15.33 %
3 Year Return
+ 120.27 %
5 Year Return
-61.74 %

Rezolute Common Stock (NV) Stock Fundamentals & Key Indicators

Check Rezolute Common Stock (NV) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$495.9M

EPS (TTM)

-0.695

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-85.8M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-81.73%

Rezolute Common Stock (NV) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Rezolute Common Stock (NV) with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$495.9M-61.74%NA0.00%NA
BUY$38.2B65.93%71.9612.55%NA
BUY$118.5B144.05%27.735.51%NA
BUY$64.2B13.51%14.9529.65%0.59%

Stock Returns calculator for Rezolute Common Stock (NV) Stock including INR - Dollar returns

The Rezolute Common Stock (NV) stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Rezolute Common Stock (NV) investment value today

Current value as on today

₹1,30,671

Returns

₹30,671

(+30.67%)

Returns from Rezolute Common Stock (NV) Stock

₹18,632 (+18.63%)

Dollar Impact

₹12,039 (+12.04%)

Analyst Recommendation on Rezolute Common Stock (NV) Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Rezolute Common Stock (NV). Average target price of $7.67

Rezolute Common Stock (NV) Share Price Target

Get share price movements and forecasts by analysts on Rezolute Common Stock (NV).

What analysts predicted

34.42%UPSIDE

Target Price

$7.67

Current Price

$5.03

Analyzed by

13 Analysts

Target

$7.67

Rezolute Common Stock (NV) target price $7.67, a slight upside of 34.42% compared to current price of $5.03. According to 13 analysts rating.

Indian Investors' Interest in Rezolute Common Stock (NV) Stock

Search interest for Rezolute Common Stock (NV) Stock has increased by 136% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:136% versus previous 30 day period

Rezolute Common Stock (NV) Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
0
-
-
-
0
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-15
-16
-23
-16
-17
-20
-25
-19
-24
-17
EBITDA
-13
-17
-22
-15
-15
-18
-24
-18
-22
-16
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-13
-17
-22
-15
-15
-18
-24
-18
-22
-16
Income Tax Expense
-
0
0
-
-
-
-
-
-
-
Net Income
-13
-17
-22
-15
-15
-18
-24
-18
-22
-16
Net Profit Margin
0.00%
0.00%
-39613.79%
0.00%
0.00%
0.00%
-53021.74%
0.00%
0.00%
0.00%

Rezolute Common Stock (NV) Annual Profit & Loss

All numbers in Millions USD

Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-8
-12
-
0
0
0
0
0
0
0
Operating Income
-14
-20
-28
-25
-20
-22
-41
-55
-70
-79
EBITDA
-14
-19
-25
-25
-20
-20
-39
-51
-68
-74
Interest Expense
0
0
0
4
0
0
1
0
-
-
Depreciation
-
1
1
0
0
0
0
0
0
0
Income Before Tax
-14
-20
-29
-30
-20
-20
-41
-51
-68
-74
Income Tax Expense
0
0
2
0
0
0
-2
0
69
-
Net Income
-14
-20
-29
-30
-20
-20
-41
-51
-68
-74
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Rezolute Common Stock (NV) Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-17
-22
-15
-15
-18
-24
-18
-22
-16
Operating Cash Flow
-15
-18
-16
-13
-17
-21
-17
-20
-13
Investing Cash Flow
8
19
-49
11
23
0
-68
22
12
Financing Cash Flow
0
63
5
0
0
101
0
0
0
Change in Cash
-6
64
-59
-1
5
79
-85
2
0

Rezolute Common Stock (NV) Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-20
-29
-30
-20
-20
-41
-51
-68
-74
Operating Cash Flow
-13
-14
-15
-24
-20
-39
-44
-57
-69
Investing Cash Flow
0
1
0
-101
-101
-101
-101
48
-14
Financing Cash Flow
13
9
25
22
51
148
11
63
107
Change in Cash
0
-2
9
-1
31
109
-134
54
23

Global Institutional Holdings in Rezolute Common Stock (NV)

Funds
Holdings
Opaleye Management Inc
6.54%
Blackstone Inc
3.16%
Vanguard Group Inc
4.97%
Marshall Wace Asset Management Ltd
2.85%
Point72 Asset Management, L.P.
1.21%

Rezolute Common Stock (NV) News & Key Events

  • img

    Today's Timeline - 11 December

    Thu, 11:03 PM

    -

    Rezolute's Phase 3 trial for ersodetug fails, leading to a 90% stock price drop.

Insights on Rezolute Common Stock (NV)

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, RZLT has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, RZLT stock has moved up by 50.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 18.3% return, outperforming this stock by 3.0%

About Rezolute Common Stock (NV)

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
OrganisationRezolute Common Stock (NV)
Headquarters275 Shoreline Drive, Redwood City, CA, United States, 94065
IndustryBiotechnology
CEOMr. Nevan Charles Elam J.D.
E-voting on sharesClick here to vote

Key Management of Rezolute Common Stock (NV)

Name

Title

Mr. Nevan Charles Elam J.D.

Founder, CEO, Principal Financial Officer & Acting Chairman of the Board

Dr. Brian Kenneth Roberts M.D.

Chief Medical Officer

Mr. Michael R. Deperro

Senior VP & Head of Operations

Dr. Davelyn Eaves Hood M.B.A., M.D.

Director and Head of Scientific & Patient Affairs

Dr. Raj Agrawal M.D.

VP & Head of Ophthalmological Clinical Development

Mr. Daron G. Evans M.B.A., M.S.

Chief Financial & Business Officer

Ms. Melissa Quinn

Senior Director of People and Culture

Mr. Michael Covarrubias

Senior VP & Head of Program & Portfolio Management

Mr. Chris Milks

VP & Head of Finance

Ms. Robyn Sweinhart

VP & Head of Quality

FAQs

What is Rezolute Common Stock (NV) share price today?

Rezolute Common Stock (NV) share price today is $5.03 as on . Rezolute Common Stock (NV) share today touched a day high of $5.25 and a low of $4.9.

What is the 52 week high and 52 week low for Rezolute Common Stock (NV) share?

Rezolute Common Stock (NV) share touched a 52 week high of $11.46 on and a 52 week low of $1.07 on . Rezolute Common Stock (NV) stock price today i.e. is trending at $5.03,which is 56.09% down from its 52 week high and 370.09% up from its 52 week low.

What is Rezolute Common Stock (NV)'s market capitalisation today?

Rezolute Common Stock (NV) market capitalisation is $0.00T as on .

How to invest in Rezolute Common Stock (NV) Stock (RZLT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Rezolute Common Stock (NV) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rezolute Common Stock (NV) Shares that will get you 0.2982 shares as per Rezolute Common Stock (NV) share price of $5.03 per share as on June 25, 2026 at 12:57 am IST.

What is the minimum amount required to buy Rezolute Common Stock (NV) Stock (RZLT) from India?

Indian investors can start investing in Rezolute Common Stock (NV) (RZLT) shares with as little as ₹94.665 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.65 in Rezolute Common Stock (NV) stock (as per the Rupee-Dollar exchange rate as on ). Based on Rezolute Common Stock (NV) share’s latest price of $5.03 as on June 25, 2026 at 12:57 am IST, you will get 1.9881 shares of Rezolute Common Stock (NV). Learn more about fractional shares .

What are the returns that Rezolute Common Stock (NV) has given to Indian investors in the last 5 years?

Rezolute Common Stock (NV) stock has given -61.74% share price returns and 27.62% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?